Navigation Links
Reportlinker Adds Driving Successful Pharma Brands: Case Studies of Real Product Launches
Date:10/29/2009

NEW YORK, Oct. 29 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue.

Driving Successful Pharma Brands: Case Studies of Real Product Launches

http://www.reportlinker.com/p0154039/Driving-Successful-Pharma-Brands--Case-Studies-of-Real-Product-Launches.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=prnewswire

Make all the right spending choices at the right time -- and maximize product sales performance. Driving Successful Pharma Brands: Case Studies of Real Product Launches delivers original analysis and real, phase-by-phase marketing budgets for 13 US brands of all sizes, representing various therapeutic areas, drug classes and sales potentials. Each easy-to-access brand profile details critical components of a brand's commercialization efforts, including sampling, journal ads, DTC advertising, thought leader development, medical education, market research, competitive intelligence, reimbursement and more.

STRATEGY Take the guesswork out of your spending decisions. If you need evidence to get more funding, justify shifting existing funding to more important activities or simply wish to benchmark your spending levels to some of pharma's leading companies, this report contains the data and analysis you need.

SUPPORT Back your position with the power of industry intelligence. Our report gives you support for your ideas and prepares you for meetings, presentations and strategy discussions with key executives. Learn from real-world models revealing top companies' strategies for allocating resources and developing a marketing mix.

SUCCESS Our reports are ready to use from the moment you get them. Skim the chapter introductions and high-level data charts to get a quick understanding of the brands and key concepts. Then read the brand profiles that interest you the most -- and find the detail and data you need for your own plans. Throughout the report, you will learn from extensive metrics, charts and data analyses.

Executive Summary

Profiled Companies

Methodology and Definitions

Pharmaceutical Product Commercialization: Five Principles for Success

Large Company Brand 1

Phase 3a Resources

Phase 3b Resources

Launch Resources

Large Company Brand 2

Phase 3a Resources

Phase 3b Resources

Launch Resources

Large Company Brand 3

Phase 3a Resources

Phase 3b Resources

Launch Resources

Large Company Brand 4

Phase 3a Resources

Phase 3b Resources

Launch Resources

Large Company Brand 5

Launch Year Resources

Large Company Brand 6

Phase 3a Resources

Phase 3b Resources

Launch Resources

Large Company Survey Data

Advertising and Promotion Spending

Medical Affairs

Decision Support

Market Access

Small Company Brand 1

Preclinical Resources

Phase 1 Resources

Phase 2 Resources

Phase 3a Resources

Phase 3b Resources

Launch Resources

Advertising and Promotion Spending

Medical Affairs Spending

Decision Support Spending

Market Access Spending

Small Company Brand 2

Phase 2 Resources

Phase 3a Resources

Phase 3b Resources

Launch Resources

Advertising and Promotion Spending

Medical Affairs Spending

Decision Support Spending

Market Access Spending

Small Company Brand 3 (EU Market)

Phase 2 Resources

Phase 3a Resources

Phase 3b Resources

Launch Resources

Advertising and Promotion Spending

Medical Affairs Spending

Decision Support Spending

Market Access Spending

Small Company Brand 4

Phase 3a Resources

Launch Resources

Advertising and Promotion Spending

Medical Affairs Spending

Decision Support Spending

Market Access Spending

Small Company Brand 5

Preclinical Resources

Phase 1 Spending

Phase 2 Resources

Phase 3a Resources

Advertising and Promotion Spending

Medical Affairs Spending

Decision Support Spending

Market Access Spending

Small Company Brand 6

Preclinical through Phase 2 Resources

Phase 3a Resources

Phase 3b Resources

Launch Resources

Advertising and Promotion Spending

Medical Affairs Spending

Decision Support Spending

Market Access Spending

Small Company Brand 7

Preclinical and Phase 1 Resources

Phase 2 Resources

Phase 3a Resources

Phase 3b Resources

Launch Resources

Advertising and Promotion Spending

Medical Affairs Spending

Decision Support Spending

Market Access Spending

Small Company Survey Data

Advertising and Promotion Spending

Medical Affairs

Decision Support

Market Access

Executive Summary

Figure E.1: Large Company Brands: Cumulative Spending and Peak Sales

Figure E.2: Small Company Brands: Cumulative Spending and Peak Sales

Figure E.3: Large Company Brands: Percentage of Total Commercialization Spending by Category

Figure E.4: Small Company Brands: Percentage of Total Commercialization Spending by Category

Figure E.5: Large Company Brands: Major Categories as a Percentage of Total Spending

Figure E.6: Small Company Brands: Major Categories as a Percentage of Total Spending

Figure E.7: Large Company Brands: Phase-by-Phase Percentage of Commercialization Spending by Category

Figure E.8: Small Company Brands: Phase-by-Phase Percentage of Commercialization Spending by Category

Large Company Brand 1

Figure 1.1: Large Company Brand 1 Dashboard

Figure 1.2: Large Company Brand 1 Total Commercialization Spend by Phase

Phase 3a Resources

Figure 1.3: Large Company Brand 1 Phase 3a Spending

Figure 1.4: Large Company Brand 1 Phase 3a Spending Percentage Breakdown

Phase 3b Resources

Figure 1.5: Large Company Brand 1 Phase 3b Spending

Figure 1.6: Large Company Brand 1 Phase 3b Spending Percentage Breakdown

Figure 1.7: Large Company Brand 1 Launch Year Spending Launch Resources

Figure 1.8: Large Company Brand 1 Launch Spending Percentage Breakdown

Figure 1.9: Large Company Brand 1 Detail Aids Spending

Figure 1.10: Large Company Brand 1 Samples Spending

Figure 1.11: Large Company Brand 1 Journal Ads

Figure 1.12: Large Company Brand 1 Patient Education Spending

Figure 1.13: Large Company Brand 1 Speakers Spending

Figure 1.14: Large Company Brand 1 Thought Leader Development Spending

Figure 1.15: Large Company Brand 1 Thought Leader Programs Spending

Figure 1.16: Large Company Brand 1 Medical Education Spending

Figure 1.17: Large Company Brand 1 Medical Information Spending

Figure 1.18: Large Company Brand 1 Market Research Spending

Figure 1.19: Large Company Brand 1 Pricing Spending

Figure 1.20: Large Company Brand 1 Reimbursement Spending

Large Company Brand 2

Figure 2.1: Large Company Brand 2 Dashboard

Figure 2.2: Large Company Brand 2 Total Commercialization Spend by Phase

Phase 3a Resources

Figure 2.3: Large Company Brand 2 Phase 3b Spending

Phase 3b Resources

Figure 2.4: Large Company Brand 2 Phase 3b Spending Percentage Breakdown

Figure 2.5: Large Company Brand 2 Launch Year Spending

Launch Resources

Figure 2.6: Large Company Brand 2 Launch Spending Percentage Breakdown

Figure 2.7: Large Company Brand 2 Detail Aids Spending

Figure 2.8: Large Company Brand 2 Samples Spending

Figure 2.9: Large Company Brand 2 Journal Ads

Figure 2.10: Large Company Brand 2 Patient Education Spending

Figure 2.12: Large Company Brand 2 Speakers Spending

Figure 2.11: Large Company Brand 2 DTC Spending

Figure 2.14: Large Company Brand 2 Thought Leader Programs Spending

Figure 2.13: Large Company Brand 2 Thought Leader Development Spending

Figure 2.15: Large Company Brand 2 Medical Education Spending

Figure 2.16: Large Company Brand 2 Medical Information Spending

Figure 2.17: Large Company Brand 2 Market Research Spending

Figure 2.18: Large Company Brand 2 Competitive Intelligence Spending

Figure 2.19: Large Company Brand 2 Pricing Spending

Figure 2.20: Large Company Brand 2 Pharmacoeconomics Spending

Figure 2.21: Large Company Brand 2 Reimbursement Spending

Large Company Brand 3

Figure 3.1: Large Company Brand 3 Dashboard

Figure 3.2: Large Company Brand 3 Total Commercialization Spend by Phase

Phase 3a Resources

Figure 3.3: Large Company Brand 3 Phase 3b Spending

Phase 3b Resources

Figure 3.4: Large Company Brand 3 Phase 3b Spending Percentage Breakdown

Figure 3.5: Large Company Brand 3 Launch Year Spending

Launch Resources

Figure 3.6: Large Company Brand 3 Launch Year Spending Percentage Breakdown

Figure 3.7: Large Company Brand 3 Detail Aids Spending

Figure 3.8: Large Company Brand 3 Samples Spending

Figure 3.9: Large Company Brand 3 Journal Ads

Figure 3.10: Large Company Brand 3 Patient Education Spending

Figure 3.11: Large Company Brand 3 DTC Spending

Figure 3.12: Large Company Brand 3 Speakers Spending

Figure 3.13: Large Company Brand 3 Thought Leader Development Spending

Figure 3.14: Large Company Brand 3 Thought Leader Programs Spending

Figure 3.15: Large Company Brand 3 Medical Education Spending

Figure 3.16: Large Company Brand 3 Medical Information Spending

Figure 3.17: Large Company Brand 3 Market Research Spending

Figure 3.18: Large Company Brand 3 Competitive Intelligence Spending

Figure 3.19: Large Company Brand 3 Pricing Spending

Figure 3.20: Large Company Brand 3 Pharmacoeconomics Spending

Figure 3.21: Large Company Brand 3 Reimbursement Spending

Large Company Brand 4

Figure 4.1: Large Company Brand 4 Dashboard

Figure 4.2: Large Company Brand 4 Total Commercialization Spend by Phase

Figure 4.3: Large Company Brand 4 Phase 3a Spending

Phase 3a Resources

Figure 4.4: Large Company Brand 4 Phase 3a Spending Percentage Breakdown

Figure 4.5: Large Company Brand 4 Phase 3b Spending

Phase 3b Resources

Figure 4.6: Large Company Brand 4 Phase 3b Spending Percentage Breakdown

Figure 4.7: Large Company Brand 4 Launch Spending

Launch Resources

Figure 4.8: Large Company Brand 4 Launch Spending Percentage Breakdown

Figure 4.9: Large Company Brand 4 Detail Aids Spending

Figure 4.10: Large Company Brand 4 Journal Ads

Figure 4.11: Large Company Brand 4 Patient Education Spending

Figure 4.12: Large Company Brand 4 DTC Spending

Figure 4.13: Large Company Brand 4 Speakers Spending

Figure 4.14: Large Company Brand 4 Thought Leader Development Spending

Figure 4.15: Large Company Brand 4 Thought Leader Programs Spending

Figure 4.16: Large Company Brand 4 Medical Education Spending

Figure 4.17: Large Company Brand 4 Medical Information Spending

Figure 4.18: Large Company Brand 4 Market Research Spending

Figure 4.19: Large Company Brand 4 Competitive Intelligence Spending

Figure 4.20: Large Company Brand 4 Pricing Spending

Figure 4.21: Large Company Brand 4 Pharmacoeconomics Spending

Figure 4.22: Large Company Brand 4 Reimbursement Spending

Large Company Brand 5

Figure 5.1: Large Company Brand 5 Dashboard

Figure 5.2: Large Company Brand 5 Total Commercialization Spend by Phase

Figure 5.3: Large Company Brand 5 Launch Year Spending

Launch Year Resources

Figure 5.4: Large Company Brand 5 Launch Year Spending Percentage Breakdown

Figure 5.5: Large Company Brand 5 Detail Aids Spending

Figure 5.6: Large Company Brand 5 Samples Spending

Figure 5.7: Large Company Brand 5 Journal Ads

Figure 5.8: Large Company Brand 5 Patient Education Spending

Figure 5.9: Large Company Brand 5 DTC Spending

Figure 5.10: Large Company Brand 5 Speakers Spending

Figure 5.11: Large Company Brand 5 Thought Leader Development Spending

Figure 5.12: Large Company Brand 5 Thought Leader Programs Spending

Figure 5.13: Large Company Brand 5 Medical Education Spending

Figure 5.14: Large Company Brand 5 Medical Information Spending

Figure 5.15: Large Company Brand 5 Market Research Spending

Figure 5.16: Large Company Brand 5 Competitive Intelligence Spending

Figure 5.17: Large Company Brand 5 Pricing Spending

Figure 5.18: Large Company Brand 5 Pharmacoeconomics Spending

Figure 5.19: Large Company Brand 5 Reimbursement Spending

Large Company Brand 6

Figure 6.1: Large Company Brand 6 Dashboard

Figure 6.2: Large Company Brand 6 Total Commercialization Spend by Phase

Figure 6.3: Large Company Brand 6 Phase 3a Spending

Phase 3a Resources

Figure 6.4: Large Company Brand 6 Phase 3a Spending Percentage Breakdown

Figure 6.5: Large Company Brand 6 Phase 3b Spending

Phase 3b Resources

Figure 6.6: Large Company Brand 6 Phase 3b Spending Percentage Breakdown

Launch Resources

Figure 6.7: Large Company Brand 6 Phase Launch Year Spending

Figure 6.8: Large Company Brand 6 Launch Year Spending Percentage Breakdown

Figure 6.9: Large Company Brand 6 Detail Aids Spending

Figure 6.10: Large Company Brand 6 Samples Spending

Figure 6.11: Large Company Brand 6 Journal Ads

Figure 6.12: Large Company Brand 6 Patient Education Spending

Figure 6.13: Large Company Brand 6 DTC Spending

Figure 6.14: Large Company Brand 6 Speakers Spending

Figure 6.15: Large Company Brand 6 Thought Leader Development Spending

Figure 6.16: Large Company Brand 6 Thought Leader Programs Spending

Figure 6.17: Large Company Brand 6 Medical Education Spending

Figure 6.18: Large Company Brand 6 Medical Information Spending

Figure 6.19: Large Company Brand 6 Market Research Spending

Figure 6.20: Large Company Brand 6 Competitive Intelligence Spending

Figure 6.21: Large Company Brand 6 Pricing Spending

Figure 6.22: Large Company Brand 6 Pharmacoeconomics Spending

Figure 6.23: Large Company Brand 6 Reimbursement Spending

Large Company Survey Data

Advertising and Promotion Spending

Figure 7.1: Large Company Brands: Advertising and Promotion Spending by Year

Figure 7.2: Large Company Brands: Breakdown of Advertising and Promotion Spending

Figure 7.3: Large Company Brands: Advertising and Promotion Spending: Detail Aids

Figure 7.4: Large Company Brands: Breakdown of Detail Aids Spending

Figure 7.5: Large Company Brands: Advertising and Promotion Spending: Samples

Figure 7.6: Large Company Brands: Breakdown of Samples Spending

Figure 7.7: Large Company Brands: Advertising and Promotion Spending:

Large Company Brands: Journal Ads

Figure 7.8: Large Company Brands: Breakdown of Journal Ads Spending

Figure 7.9: Large Company Brands: Advertising and Promotion Spending:

Large Company Brands: Patient Education

Figure 7.10: Large Company Brands: Breakdown of Patient Education Spending

Figure 7.11: Large Company Brands: Advertising and Promotion Spending: DTC

Figure 7.12: Large Company Brands: Breakdown of DTC Spending

Figure 7.13: Large Company Brands: Advertising and Promotion Spending: Speakers

Figure 7.14: Large Company Brands: Breakdown of Speakers Spending

Medical Affairs

Figure 7.15: Large Company Brands: Medical Affairs Spending by Year

Figure 7.16: Large Company Brands: Breakdown of Medical Affairs Spending

Figure 7.17: Large Company Brands: Thought Leader Development Spending

Figure 7.18: Large Company Brands: Breakdown of Thought Leader

Development Spending

Figure 7.19: Large Company Brands: Thought Leader Programs Spending

Figure 7.20: Large Company Brands: Breakdown of Thought Leader

Programs Spending

Figure 7.21: Large Company Brands: Medical Affairs Spending: Medical Education

Figure 7.22: Large Company Brands: Breakdown of Medical Education Spending

Figure 7.23: Large Company Brands: Medical Affairs Spending: Medical Information

Figure 7.24: Large Company Brands: Breakdown of Medical Information Spending

Decision Support

Figure 7.25: Large Company Brands: Decision Support Spending by Year

Figure 7.26: Large Company Brands: Breakdown of Decision Support Spending

Figure 7.27: Large Company Brands: Market Research Spending

Figure 7.28: Large Company Brands: Breakdown of Market Research Spending

Figure 7.29: Large Company Brands: Competitive Intelligence Spending

Figure 7.30: Large Company Brands: Breakdown of Competitive Intelligence Spending

Market Access

Figure 7.31: Large Company Brands: Market Access Spending by Year

Figure 7.32: Large Company Brands: Breakdown of Market Access Spending

Figure 7.33: Large Company Brands: Market Access Spending: Pricing

Figure 7.34: Large Company Brands: Breakdown of Pricing Spending

Figure 7.8: Large Company Brands: Breakdown of Journal Ads Spending

Figure 7.9: Large Company Brands: Advertising and Promotion Spending:

Large Company Brands: Patient Education

Figure 7.10: Large Company Brands: Breakdown of Patient Education Spending

Figure 7.11: Large Company Brands: Advertising and Promotion Spending: DTC

Figure 7.12: Large Company Brands: Breakdown of DTC Spending

Figure 7.13: Large Company Brands: Advertising and Promotion Spending: Speakers

Figure 7.14: Large Company Brands: Breakdown of Speakers Spending

Medical Affairs

Figure 7.15: Large Company Brands: Medical Affairs Spending by Year

Figure 7.16: Large Company Brands: Breakdown of Medical Affairs Spending

Figure 7.17: Large Company Brands: Thought Leader Development Spending

Figure 7.18: Large Company Brands: Breakdown of Thought Leader

Development Spending

Figure 7.19: Large Company Brands: Thought Leader Programs Spending

Figure 7.20: Large Company Brands: Breakdown of Thought Leader

Programs Spending

Figure 7.21: Large Company Brands: Medical Affairs Spending: Medical Education

Figure 7.22: Large Company Brands: Breakdown of Medical Education Spending

Figure 7.23: Large Company Brands: Medical Affairs Spending: Medical Information

Figure 7.24: Large Company Brands: Breakdown of Medical Information Spending

Decision Support

Figure 7.25: Large Company Brands: Decision Support Spending by Year

Figure 7.26: Large Company Brands: Breakdown of Decision Support Spending

Figure 7.27: Large Company Brands: Market Research Spending

Figure 7.28: Large Company Brands: Breakdown of Market Research Spending

Figure 7.29: Large Company Brands: Competitive Intelligence Spending

Figure 7.30: Large Company Brands: Breakdown of Competitive Intelligence Spending

Market Access

Figure 7.31: Large Company Brands: Market Access Spending by Year

Figure 7.32: Large Company Brands: Breakdown of Market Access Spending

Figure 7.33: Large Company Brands: Market Access Spending: Pricing

Figure 7.34: Large Company Brands: Breakdown of Pricing Spending

Figure 7.35: Large Company Brands: Market Access Spending: Pharmacoeconomics

Figure 7.36: Large Company Brands: Breakdown of Pharmacoeconomics Spending

Figure 7.37: Large Company Brands: Market Access Spending: Reimbursement

Figure 7.38: Large Company Brands: Breakdown of Reimbursement Spending

Small Company Brand 1

Figure 8.1: Small Company Brand 1: Brand Dashboard

Figure 8.2: Small Company Brand 1: Phase by Phase Spending (in millions)

Figure 8.3: Small Company Brand 1: Phase Spending as a Percentage of

Total Commercialization

Figure 8.4: Small Company Brand 1: Length of Development Phases (in months)

Figure 8.5: Small Company Brand 1: Preclinical Spending

Preclinical Resources

Figure 8.6: Small Company Brand 1: Preclinical Spending Percentage Breakdown

Figure 8.7: Small Company Brand 1: Phase 1 Spending

Phase 1 Resources

Figure 8.8: Small Company Brand 1: Phase 1 Spending Percentage Breakdown

Figure 8.9: Small Company Brand 1: Phase 2 Spending

Phase 2 Resources

Figure 8.10: Small Company Brand 1: Phase 2 Spending Percentage Breakdown

Figure 8.11: Small Company Brand 1: Phase 3a Spending

Phase 3a Resources

Figure 8.12: Small Company Brand 1: Phase 3a Spending Percentage Breakdown

Figure 8.13: Small Company Brand 1: Phase 3b Spending

Phase 3b Resources

Figure 8.14: Small Company Brand 1: Phase 3b Spending Percentage Breakdown

Figure 8.15: Small Company Brand 1: Launch Year Spending

Launch Resources

Figure 8.16: Small Company Brand 1: Launch Year Spending Percentage Breakdown

Figure 8.17: Small Company Brand 1: Detail Aids Spending

Advertising and Promotion Spending

Figure 8.18: Small Company Brand 1: Sample Spending

Figure 8.19: Small Company Brand 1: Journal Ads Spending

Figure 8.20: Small Company Brand 1: Patient Education Spending

Figure 8.21: Small Company Brand 1: DTC Spending

Figure 8.22: Small Company Brand 1: Speakers Spending

Figure 8.23: Small Company Brand 1: Thought Leader Development Spending

Medical Affairs Spending

Figure 8.24: Small Company Brand 1: Thought Leader Programs Spending

Figure 8.25: Small Company Brand 1: Medical Education Spending

Figure 8.26: Small Company Brand 1: Medical Information

Figure 8.27: Brand 1: Market Research Spending

Decision Support Spending

Figure 8.28: Brand 1: Competitive Intelligence Spending

Figure 8.29: Small Company Brand 1: Pricing Spending

Market Access Spending

Figure 8.30: Small Company Brand 1: Pharmacoeconomics Spending

Figure 8.31: Small Company Brand 1: Reimbursement Spending

Small Company Brand 2

Figure 9.1: Small Company Brand 2: Brand Dashboard

Figure 9.2: Small Company Brand 2: Length of Development Phases (in Months)

Figure 9.3: Small Company Brand 2: Phase by Phase Spending

Figure 9.4: Small Company Brand 2: Phase Spending as a Percentage of

Total Commercialization

Figure 9.5: Small Company Brand 2: Phase 2 Spending

Phase 2 Resources

Figure 9.6: Small Company Brand 2: Phase 2 Spending Percentage Breakdown

Figure 9.7: Small Company Brand 2: Phase 3a Spending

Phase 3a Resources

Figure 9.8: Small Company Brand 2: Phase 3a Spending Percentage Breakdown

Figure 9.9: Small Company Brand 2: Phase 3b Spending

Phase 3b Resources

Figure 9.10: Small Company Brand 2: Phase 3b Spending Percentage Breakdown

Figure 9.11: Small Company Brand 2: Launch Year Spending

Launch Resources

Figure 9.12: Small Company Brand 2: Launch Year Spending Percentage Breakdown

Figure 9.13: Small Company Brand 2: Detail Aids Spending

Advertising and Promotion Spending

Figure 9.14: Small Company Brand 2: Sample Spending

Figure 9.15: Small Company Brand 2: Journal Ads Spending

Figure 9.16: Small Company Brand 2: Patient Education Spending

Figure 9.17: Small Company Brand 2: DTC Spending

Figure 9.18: Small Company Brand 2: Speakers Spending

Figure 9.19: Small Company Brand 2: Thought Leader Development Spending

Medical Affairs Spending

Figure 9.20: Small Company Brand 2: Thought Leader Programs Spending

Figure 9.21: Small Company Brand 2: Medical Education Spending

Figure 9.22: Small Company Brand 2: Medical Information

Figure 9.23: Small Company Brand 2: Market Research Spending

Decision Support Spending

Figure 9.24: Small Company Brand 2: Competitive Intelligence Spending

Figure 9.25: Small Company Brand 2: Pricing Spending

Market Access Spending

Figure 9.26: Small Company Brand 2: Pharmacoeconomics Spending

Figure 9.27: Small Company Brand 2: Reimbursement Spending

Small Company Brand 3 (EU Market)

Figure 10.1: Small Company Brand 3: Brand Dashboard

Figure 10.2: Small Company Brand 3: Length of Development Phases (in Months)

Figure 10.3: Small Company Brand 3: Phase-by-Phase Spending

Figure 10.4: Small Company Brand 3: Phase Spending as a Percentage of

Total Commercialization

Figure 10.5: Small Company Brand 3: Phase 2 Spending

Phase 2 Resources

Figure 10.6: Small Company Brand 3: Phase 2 Spending Percentage Breakdown

Figure 10.7: Small Company Brand 3: Phase 3a Spending

Phase 3a Resources

Figure 10.8: Small Company Brand 3: Phase 3a Spending Percentage Breakdown

Figure 10.9: Small Company Brand 3: Phase 3b Spending

Phase 3b Resources

Figure 10.10: Small Company Brand 3: Phase 3b Spending Percentage Breakdown

Figure 10.11: Small Company Brand 3: Year 1 Spending

Launch Resources

Figure 10.12: Small Company Brand 3: Year 1 Spending Percentage Breakdown

Advertising and Promotion Spending

Figure 10.13: Small Company Brand 3 Detail Aids Spending

Figure 10.14: Small Company Brand 3 Samples Spending

Figure 10.15: Small Company Brand 3 Journal Ads Spending

Figure 10.16: Small Company Brand 3 Patient Education Spending

Figure 10.17: Small Company Brand 3 DTC Spending

Figure 10.18: Small Company Brand 3 Speakers Spending

Figure 10.19: Small Company Brand 3 Thought Leader Development Spending

Medical Affairs Spending

Figure 10.20: Small Company Brand 3 Thought Leader Programs Spending

Figure 10.21: Small Company Brand 3 Medical Education Spending

Figure 10.22: Small Company Brand 3 Medical Information Spending

Figure 10.23: Small Company Brand 3 Market Research Spending

Decision Support Spending

Figure 10.24: Small Company Brand 3 Competitive Intelligence Spending

Figure 10.25: Small Company Brand 3 Pricing Spending

Market Access Spending

Figure 10.26: Small Company Brand 3 Pharmacoeconomics Spending

Figure 10.27: Small Company Brand 3 Reimbursement Spending

Small Company Brand 4

Figure 11.1: Small Company Brand 4: Brand Dashboard

Figure 11.2: Small Company Brand 4: Market Analysts Sales Projections (in millions)

Figure 11.3: Small Company Brand 4: Length of Development Phases (in Months)

Figure 11.4: Small Company Brand 4: Phase-by-Phase Spending

Figure 11.5: Small Company Brand 4: Phase Spending as a Percentage of Total Commercialization

Phase 3a Resources

Figure 11.6: Small Company Brand 4: Phase 3a Spending

Figure 11.7: Small Company Brand 4: Phase 3a Spending Percentage Breakdown

Launch Resources

Figure 11.8: Small Company Brand 4: Year 1 Spending

Figure 11.9: Small Company Brand 4: Year 1 Spending Percentage Breakdown

Advertising and Promotion Spending

Figure 11.10: Small Company Brand 4 Detail Aids Spending

Figure 11.11: Small Company Brand 4 Samples Spending

Figure 11.12: Small Company Brand 4 Journal Ads Spending

Figure 11.13: Small Company Brand 4 Patient Education Spending

Figure 11.14: Small Company Brand 4 DTC Spending

Figure 11.15: Small Company Brand 4 Speakers Spending

Figure 11.16: Small Company Brand 4 Thought Leader Development Spending

Medical Affairs Spending

Figure 11.17: Small Company Brand 4 Thought Leader Programs Spending

Figure 11.18: Small Company Brand 4 Medical Education Spending

Figure 11.19: Small Company Brand 4 Medical Information Spending

Figure 11.20: Small Company Brand 4 Market Research Spending

Decision Support Spending

Figure 11.21: Small Company Brand 4 Competitive Intelligence Spending

Figure 11.22: Small Company Brand 4 Pricing Spending

Market Access Spending

Figure 11.23: Small Company Brand 4 Pharmacoeconomics Spending

Figure 11.24: Small Company Brand 4 Reimbursement Spending

Small Company Brand 5

Figure 12.1: Small Company Brand 5: Brand Dashboard

Figure 12.2: Small Company Brand 5: Length of Development Phases (in Months)

Figure 12.3: Small Company Brand 5: Phase-by-Phase Spending

Figure 12.4: Small Company Brand 5: Preclinical Spending

Preclinical Resources

Figure 12.5: Small Company Brand 5: Preclinical Spending Percentage Breakdown

Figure 12.6: Small Company Brand 5: Phase 1 Spending

Phase 1 Spending

Figure 12.7: Small Company Brand 5: Phase 1 Spending Percentage Breakdown

Figure 12.8: Small Company Brand 5: Phase 2 Spending

Phase 2 Resources

Figure 12.9: Small Company Brand 5: Phase 2 Spending Percentage Breakdown

Figure 12.10: Small Company Brand 5: Phase 3a Spending

Phase 3a Resources

Figure 12.11: Small Company Brand 5: Phase 3a Spending Percentage Breakdown

Figure 12.12: Small Company Brand 5 Detail Aids Spending

Advertising and Promotion Spending

Figure 12.13: Small Company Brand 5 Samples Spending

Figure 12.14: Small Company Brand 5 Journal Ads Spending

Figure 12.15: Small Company Brand 5 Patient Education Spending

Figure 12.16: Small Company Brand 5 DTC Spending

Figure 12.17: Small Company Brand 5 Speakers Spending

Figure 12.18: Small Company Brand 5 Thought Leader Development Spending

Medical Affairs Spending

Figure 12.19: Small Company Brand 5 Thought Leader Programs Spending

Figure 12.20: Small Company Brand 5 Medical Education Spending

Figure 12.21: Small Company Brand 5 Medical Information Spending

Figure 12.22: Small Company Brand 5 Market Research Spending

Decision Support Spending

Figure 12.23: Small Company Brand 5 Competitive Intelligence Spending

Figure 12.24: Small Company Brand 5 Pricing Spending

Market Access Spending

Figure 12.25: Small Company Brand 5 Pharmacoeconomics Spending

Figure 12.26: Small Company Brand 5 Reimbursement Spending

Small Company Brand 6

Figure 13.1: Small Company Brand 6: Brand Dashboard

Figure 13.2: Small Company Brand 6: Phase by Phase Spending (in millions)

Figure 13.3: Small Company Brand 6: Phase Spending as a Percentage of Total Commercialization

Figure 13.4: Small Company Brand 6: Length of Development Phases

Figure 13.5: Small Company Brand 6: Phase 2 Spending

Preclinical through Phase 2 Resources

Figure 13.6: Small Company Brand 6: Phase 2 Spending Percentage Breakdown

Figure 13.7: Small Company Brand 6: Phase 3a Spending

Phase 3a Resources

Figure 13.8: Small Company Brand 6: Phase 3a Spending Percentage Breakdown

Figure 13.9: Small Company Brand 6: Phase 3b Spending

Phase 3b Resources

Figure 13.10: Small Company Brand 6: Phase 3b Spending Percentage Breakdown

Figure 13.11: Small Company Brand 6: Launch Year Spending

Launch Resources

Figure 13.12: Small Company Brand 6: Launch Year Spending Percentage Breakdown

Figure 13.13: Small Company Brand 6: Detail Aids Spending

Advertising and Promotion Spending

Figure 13.14: Small Company Brand 6: Sample Spending

Figure 13.15: Small Company Brand 6: Journal Ads Spending

Figure 13.16: Small Company Brand 6: Patient Education Spending

Figure 13.17: Small Company Brand 6: DTC Spending

Figure 13.18: Small Company Brand 6: Speakers Spending

Figure 13.19: Small Company Brand 6: Thought Leader Development Spending

Medical Affairs Spending

Figure 13.20: Small Company Brand 6: Thought Leader Programs Spending

Figure 13.21: Small Company Brand 6: Medical Education Spending

Figure 13.22: Small Company Brand 6: Medical Information

Figure 13.23: Small Company Brand 6: Market Research Spending

Decision Support Spending

Figure 13.24: Small Company Brand 6: Competitive Intelligence Spending

Figure 13.25: Small Company Brand 6: Pricing Spending

Market Access Spending

Figure 13.26: Small Company Brand 6: Pharmacoeconomics Spending

Figure 13.27: Small Company Brand 6: Reimbursement Spending

Small Company Brand 7

Figure 14.1: Small Company Brand 7: Brand Dashboard

Figure 14.2: Small Company Brand 7: Phase by Phase Spending (in millions)

Figure 14.3: Small Company Brand 7: Phase Spending as a Percentage of

Total Commercialization

Figure 14.4: Small Company Brand 7: Phase 1 Spending

Preclinical and Phase 1 Resources

Figure 14.5: Small Company Brand 7: Phase 1 Spending Percentage Breakdown

Figure 14.6: Small Company Brand 7: Phase 2 Spending

Phase 2 Resources

Figure 14.7: Small Company Brand 7: Phase 2 Spending Percentage Breakdown

Figure 14.8: Small Company Brand 7: Phase 3a Spending

Phase 3a Resources

Figure 14.9: Small Company Brand 7: Phase 3a Spending Percentage Breakdown

Figure 14.10: Small Company Brand 7: Phase 3b Spending

Phase 3b Resources

Figure 14.11: Small Company Brand 7: Phase 3b Spending Percentage Breakdown

Figure 14.12: Small Company Brand 7: Launch Year Spending

Launch Resources

Figure 14.13: Small Com

To order this report:

Driving Successful Pharma Brands: Case Studies of Real Product Launches

http://www.reportlinker.com/p0154039/Driving-Successful-Pharma-Brands--Case-Studies-of-Real-Product-Launches.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=prnewswire

More market research reports here!

__________________________

    Nicolas Bombourg
    Reportlinker
    Email: nbo@reportlinker.com
    US: (805)652-2626
    Intl: +1 805-652-2626

SOURCE Reportlinker


'/>"/>
SOURCE Reportlinker
Copyright©2009 PR Newswire.
All rights reserved


Related medicine technology :

1. Reportlinker Adds US Disposable Medical Supplies Market Report
2. Reportlinker Adds Gilead Sciences Inc.: PharmaVitae Profile
3. Reportlinker Adds Drug Delivery Partnering Agreements in Pharma and Biotech
4. Reportlinker Adds Global Medical Devices Industry Outlook to 2010: Marketing And Sales Strategies And The Impact of Recession And Recovery
5. Reportlinker Adds Reinventing Pharmaceutical Sales Forces
6. Reportlinker Adds Computer Assisted Coding Of Medical Information Market Shares, Strategies, and Forecasts 2008 to 2014
7. Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery
8. Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015
9. Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities
10. Reportlinker Adds Global Top 10 Chemical Companies -- Industry, Financial and SWOT Analysis
11. Reportlinker Adds Pharma 101: An Overview of the Life Sciences Industry (Analyst Insight)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... N.C. , June 24, 2016  Consumers ... decisions and regulators/payers have placed more emphasis on ... environment, patient support programs in the pharmaceutical industry ... patients, medications. Consequently, pharmaceutical companies are focusing on ... they are providing products and services that improve ...
(Date:6/24/2016)... 24, 2016  Global Blood Therapeutics, Inc. (GBT) (NASDAQ: ... novel therapeutics for the treatment of grievous blood-based ... closing of its previously announced underwritten public offering ... public offering price of $18.75 per share. All ... by GBT. GBT estimates net proceeds from the ...
(Date:6/24/2016)... , June 24, 2016 ... Markets has announced the addition of the " ... offering. This ... and provides an updated review, including its applications in ... the total market, which includes three main industries: pharmaceutical ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... ... today announced its strategic partnership with Connance, a healthcare industry leader providing ... companies’ proven, proprietary technology combine to provide health systems, hospitals and ambulatory ...
(Date:6/26/2016)... Aliso Viejo, California (PRWEB) , ... June 26, 2016 , ... ... for Final Cut Pro X. , "Film editors can give their videos a whole ... artistically," said Christina Austin - CEO of Pixel Film Studios. , ProSlice Levels ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs ... College of Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. ... treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
(Date:6/24/2016)... ... 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. In ... benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued ... Sickle Cell Disease (SCD) is a disorder of the red blood cells, which can ...
Breaking Medicine News(10 mins):